======= ESRRA ======= == Gene Information == * **Official Symbol**: ESRRA * **Official Name**: estrogen related receptor alpha * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2101|2101]] * **UniProt**: [[https://www.uniprot.org/uniprot/P11474|P11474]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ESRRA&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ESRRA|Open PubMed]] * **OMIM**: [[https://omim.org/entry/601998|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds to an ERR-alpha response element (ERRE) containing a single consensus half-site, 5'-TNAAGGTCA-3'. Can bind to the medium-chain acyl coenzyme A dehydrogenase (MCAD) response element NRRE-1 and may act as an important regulator of MCAD promoter. Binds to the C1 region of the lactoferrin gene promoter. Requires dimerization and the coactivator, PGC-1A, for full activity. The ERRalpha/PGC1alpha complex is a regulator of energy metabolism. Induces the expression of PERM1 in the skeletal muscle. {ECO:0000269|PubMed:12522104, ECO:0000269|PubMed:16150865, ECO:0000269|PubMed:17676930, ECO:0000269|PubMed:18063693, ECO:0000269|PubMed:23836911, ECO:0000269|PubMed:9271417}. |Hormone recep| |zf-C4| |positive regulation of cellular response to insulin stimulus| |steroid binding| |nuclear receptor activity| |steroid hormone receptor activity| |intercellular bridge| |regulation of osteoclast differentiation| |regulation of cellular response to insulin stimulus| |regulation of osteoblast differentiation| |regulation of myeloid leukocyte differentiation| |steroid hormone mediated signaling pathway| |fibrillar center| |response to estradiol| |microtubule cytoskeleton| |intracellular receptor signaling pathway| |hormone-mediated signaling pathway| |cartilage development| |transcription initiation from RNA polymerase II promoter| |cellular response to steroid hormone stimulus| |regulation of ossification| |DNA-templated transcription, initiation| |connective tissue development| |regulation of myeloid cell differentiation| |protein domain specific binding| |DNA-binding transcription repressor activity, RNA polymerase II-specific| |regulation of leukocyte differentiation| |response to steroid hormone| |sequence-specific DNA binding| |mitochondrion organization| |DNA-binding transcription activator activity, RNA polymerase II-specific| |regulation of hemopoiesis| |transcription by RNA polymerase II| |skeletal system development| |RNA polymerase II proximal promoter sequence-specific DNA binding| |cellular response to lipid| |cellular response to organic cyclic compound| |cellular response to hormone stimulus| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |DNA-binding transcription factor activity| |zinc ion binding| |response to lipid| |negative regulation of transcription by RNA polymerase II| |response to hormone| |response to organic cyclic compound| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |negative regulation of transcription, DNA-templated| |positive regulation of transcription by RNA polymerase II| |cellular response to endogenous stimulus| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |organic cyclic compound biosynthetic process| |negative regulation of RNA metabolic process| |negative regulation of cellular macromolecule biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |DNA binding| |negative regulation of macromolecule biosynthetic process| |response to endogenous stimulus| |negative regulation of cellular biosynthetic process| |positive regulation of transcription, DNA-templated| |negative regulation of biosynthetic process| |response to oxygen-containing compound| |DNA-binding transcription factor activity, RNA polymerase II-specific| |regulation of cell population proliferation| |cellular nitrogen compound biosynthetic process| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |regulation of immune system process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |positive regulation of RNA metabolic process| |tissue development| |macromolecule biosynthetic process| |regulation of cell differentiation| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === No hits were found. No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 3/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|2/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|1/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2495 * **Expression level (log2 read counts)**: 4.59 {{:chemogenomics:nalm6 dist.png?nolink |}}